RHHBF - Roche obesity therapy leads to ~19% weight loss in Phase 1 trial
2024-05-16 06:48:39 ET
More on Roche
- Roche: Value Remains Despite Covid-19 Revenue Growth Loss
- Roche Holding AG (RHHBY) Q1 2024 Sales/Trading Statement Call Transcript
- Q1 2024 Sales/ Trading Statement Call
- J&J, Roche, AstraZeneca poised to have highest orphan drug sales by end of decade
- FDA approves Roche's Alecensa for early stage ALK+ lung cancer